{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-21-006450","form_type":"8-K","ticker":"ZOMDF","cik":"0001684144","company_name":"Zomedica Corp.","filed_at":"2021-09-13T23:59:59+00:00","discovered_at":"2026-05-14T18:04:19.153968+00:00","generated_at":"2026-06-29T04:14:09.040222+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Zomedica appoints Sean Whelan to Board; Wolfenberg resigns as director","bullets":["Christopher Wolfenberg resigned from Zomedica Board effective Sept. 13, 2021, not due to any disagreement.","Sean Whelan appointed to fill vacancy; will chair Audit Committee.","Whelan is CEO of Encore Rehabilitation Services, former CFO of Diplomat and InfuSystem, and a CPA.","Whelan received options for 800,000 common shares at $0.57/share, vesting over 4 years.","The board change took effect immediately on September 13, 2021."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-21-006450","json":"https://secwatch.observer/filing/0001171843-21-006450.json","markdown":"https://secwatch.observer/filing/0001171843-21-006450.md","text":"https://secwatch.observer/filing/0001171843-21-006450.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1684144/000117184321006450/0001171843-21-006450-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1684144/000117184321006450/f8k_091321.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T04:14:09.040222+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"01afd7e595","claim":"Sean Whelan was appointed as member of the Board of Directors at Zomedica Corp..","evidence_excerpt":"On September 13, 2021, the Board appointed Sean Whelan as a member of the Board to fill the vacancy created by Mr. Wolfenberg’s resignation.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1684144/000117184321006450/0001171843-21-006450-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"member of the Board of Directors"}],"fact_type":"executive_change"},{"claim_id":"d0fc6cdb62","claim":"Christopher Wolfenberg resigned as member of the Board of Directors at Zomedica Corp..","evidence_excerpt":"On September 13, 2021, Christopher Wolfenberg resigned, effective immediately, as a member of the Board of Directors (the “Board”) of Zomedica Corp. (the “Company”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1684144/000117184321006450/0001171843-21-006450-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"member of the Board of Directors"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}